Pre-contraction with the thromboxane-mimetic U46619 enhances P2X receptor-mediated contractions in isolated porcine splenic artery

Purinergic Signalling

Volumn 8, Issue 2, 2012, Pages 287-293

  Roberts, R E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

ERK; P2X receptors; p38 MAP kinase; Rho kinase; Thromboxane

Indexed keywords

15 HYDROXY 11ALPHA, 9ALPHA EPOXYMETHANOPROSTA 5, 13 DIENOIC ACID; 2 (2 AMINO 3 METHOXYPHENYL) CHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL) CYCLOHEXANECARBOXAMIDE; ALPHA, BETA METHYLENEADENOSINE TRIPHOSPHATE; CALCIUM CHANNEL L TYPE; CALPHOSTIN C; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENYLEPHRINE; PROTEIN KINASE C; PURINERGIC P2X RECEPTOR; RHO KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR CALCIUM; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; SPLEEN ARTERY; SWINE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; MOLECULAR MIMICRY; ORGAN CULTURE TECHNIQUES; RECEPTORS, PURINERGIC P2X; SPLENIC ARTERY; SWINE; THROMBOXANES; UP-REGULATION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84861001819     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-011-9284-1     Document Type: Article

References (16)

1. Alexander SPH, Mathie A, Peters JA (2008) Guide to receptors and channels (GRAC), 3rd edn (2008 revision). Br J Pharmacol 153(suppl 2): S1-S209.
2. 2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: role of the ERK-MAP kinase signal transduction cascade. Br J Pharmacol 139: 156-162.
3. 2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: comparison with vasopressin-enhanced responses. Biochem Pharmacol 70: 1200-1210.
4. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JSC, Alessi DR, Cohen P (2003) The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315.
5. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105.
6. Dessy C, Kim I, Sougnez CL, Laporte R, Morgan KG (1998) A role for MAP kinase in differentiated smooth muscle contraction evoked by α-adrenoceptor stimulation. Am J Physiol 275: C1081-C1086.
7. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng JH, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K (1996) Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248.
8. Kitajima S, Ozaki H, Karaki H (1994) Role of different subtypes of P2 purinoceptor on cytosolic Ca2+ levels in rat aortic smooth muscle. Eur J Pharmacol 266: 263-267.
9. Kobayashi E, Nakano H, Morimoto M, Tamaoki T (1989) Calphostin C (UCN-1028C), a novel microbial compound, is a potent and selective inhibitor of protein kinase C. Biochem Biophys Res Commun 159: 548-553.
10. Martinka P, Lai EY, Fahling M, Jankowski V, Jankowski J, Schubert R, Gaestel M, Persson AEG, Persson PB, Patzak A (2008) Adenosine increases calcium sensitivity via receptor-independent activation of p38/MK2 pathway in mesenteric arteries. Acta Physiol 193: 37-46.
11. Morgan KG, Gangopadhyay SS (2001) Signal transduction in smooth muscle-invited review. Cross-bridge regulation by thin filament associated proteins. J Appl Physiol 91: 953-962.
12. Pakdeechote P, Rummery NM, Ralevic V, Dunn WR (2007) Raised tone reveals purinergic-mediated responses to sympathetic nerve stimulation in the rat perfused mesenteric vascular bed. Eur J Pharmacol 563: 180-186.
13. 2-adrenoceptor-mediated vasoconstriction in the porcine palmar lateral vein. J Pharmacol Exp Ther 311: 742-747.
14. 2+ sensitivity of smooth muscle and nonmuscle myosin II: modulation by G proteins, kinases, and myosin phosphatase. Physiol Rev 83: 1325-1358.
15. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Naramiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994.
16. Watts SJ (1996) Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase kinase inhibitor PD98059. J Pharmacol Exp Ther 279: 1541-1550.